---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-015139"
form_type: "8-K"
ticker: "ENSC"
cik: "0001716947"
company_name: "Ensysce Biosciences, Inc."
filed_at: "2026-04-03T23:59:59+00:00"
generated_at: "2026-05-15T07:38:18.828720+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Curtis Rosebraugh resigns from Ensysce Biosciences board

## Summary
- Resignation effective April 1, 2026; no reason given in notice.
- Rosebraugh served on the Nominating and Corporate Governance Committee until resignation.
- Resignation notice filed as Exhibit 17 to the 8-K.
- No replacement announced at this time.

## SEC filing metadata
- accession: 0001493152-26-015139
- form_type: 8-K
- ticker: ENSC
- cik: 0001716947
- company_name: Ensysce Biosciences, Inc.
- filed_at: 2026-04-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1716947/000149315226015139/0001493152-26-015139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1716947/000149315226015139/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-015139
- JSON: https://secwatch.observer/filing/0001493152-26-015139.json
- Plain text: https://secwatch.observer/filing/0001493152-26-015139.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.